Wiskott-Aldrich Syndrome
|
0.050 |
Biomarker
|
disease |
BEFREE |
When activated by Wiskott-Aldrich syndrome proteins (WASP), Arp2/3 complex nucleates branched actin filaments important for processes like cellular motility and endocytosis [1].
|
30471998 |
2018 |
Wiskott-Aldrich Syndrome
|
0.050 |
Biomarker
|
disease |
BEFREE |
ARPC1B-deficient platelets are microthrombocytes similar to those seen in Wiskott-Aldrich syndrome that show aberrant spreading consistent with loss of Arp2/3 function.
|
28368018 |
2017 |
Wiskott-Aldrich Syndrome
|
0.050 |
Biomarker
|
disease |
BEFREE |
TrkC activation led to a mobility shift of Wiskott-Aldrich syndrome family verprolin-homologous protein (WAVE)-2 which is known to orchestrate Arp2/3 activation and actin polymerization.
|
29162704 |
2018 |
Wiskott-Aldrich Syndrome
|
0.050 |
Biomarker
|
disease |
BEFREE |
We discover a key biochemical difference between Dip1 and WASP that may limit linear filament nucleation in cells; although WASP must be released for nucleation, Dip1 stays associated with Arp2/3 complex on the pointed ends of nucleated actin filaments, so Dip1 is consumed in the reaction.
|
31564494 |
2019 |
Wiskott-Aldrich Syndrome
|
0.050 |
Biomarker
|
disease |
BEFREE |
We have used both the acidic domains from actin-related protein (Arp) 2/3 complex-binding proteins such as the Wiscott-Aldrich syndrome protein (N-WASP) or cortactin, and siRNA directing toward Arp2 to inhibit viral infection.
|
15385624 |
2004 |
Virus Diseases
|
0.020 |
Biomarker
|
group |
BEFREE |
Membrane trafficking RNA interference screen identifies a crucial role of the clathrin endocytic pathway and ARP2/3 complex for Japanese encephalitis virus infection in HeLa cells.
|
30489239 |
2019 |
Virus Diseases
|
0.020 |
Biomarker
|
group |
BEFREE |
We have used both the acidic domains from actin-related protein (Arp) 2/3 complex-binding proteins such as the Wiscott-Aldrich syndrome protein (N-WASP) or cortactin, and siRNA directing toward Arp2 to inhibit viral infection.
|
15385624 |
2004 |
Vascular inflammations
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Overall, our studies demonstrate that perivascular adipose tissue-secreted Angptl2 accelerates vascular inflammation and the subsequent CVD development.
|
23333801 |
2013 |
Vascular inflammations
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Conversely, ApoE(-/-) mice crossed with transgenic mice expressing Angptl2 driven by the Tie2 promoter (ApoE(-/-)/Tie2-Angptl2 Tg), which drives Angptl2 expression in endothelial cells but not monocytes/macrophages, showed accelerated plaque formation and vascular inflammation because of increased numbers of infiltrated macrophages in atheromatous plaques.
|
24526691 |
2014 |
Tumor Promotion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Our study provides strong evidence that ANGPTL2 can function in either tumor promotion or suppression, depending on what cell type it is expressed in.
|
31727773 |
2019 |
Tumor Progression
|
0.070 |
AlteredExpression
|
phenotype |
BEFREE |
The tolloid-like 1 (TLL1) protease cleaved ANGPTL2 into fragments in vitro that did not enhance tumor progression when overexpressed in xenografts.
|
24448647 |
2014 |
Tumor Progression
|
0.070 |
AlteredExpression
|
phenotype |
BEFREE |
Overexpression of ANGPTL2 in tumor cells is associated with tumor progression and has been recognized in lung, breast, colon, and gastric cancer.
|
25564164 |
2015 |
Tumor Progression
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
Angiopoietin-like protein 2 (Angptl2) is involved in tumor progression.
|
29218246 |
2017 |
Tumor Progression
|
0.070 |
AlteredExpression
|
phenotype |
BEFREE |
Angiopoietin-like protein 2 (ANGPTL2) is associated with tumor progression while dysregulation of its expression has been observed in various types of cancer.
|
25174582 |
2014 |
Tumor Progression
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
Here, we conducted mechanistic analysis comparing ANGPTL2 function in cancer progression in a murine syngeneic model of melanoma and a mouse model of translocation renal cell carcinoma (tRCC).
|
31727773 |
2019 |
Tumor Progression
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
Arp2/3 inhibition has recently garnered more attention as it has been associated with attenuation of cancer progression, neurotoxic effects during drug abuse, and pathogen invasion of host cells.
|
31073744 |
2019 |
Tumor Progression
|
0.070 |
AlteredExpression
|
phenotype |
BEFREE |
ANGPTL2 expression was upregulated in GC tissues compared to normal gastric mucosa; and high ANGPTL2 expression was significantly associated with tumor progression, early recurrence (P = 0.003) and poor prognosis (P = 0.007).
|
26420253 |
2015 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Knockdown of ANGPTL2 in vitro significantly inhibited cell proliferation, migration, and invasion, whereas it enhanced anoikis.
|
25294915 |
2014 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer.
|
19145645 |
2009 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
ANGPTL2 contributed to proliferation and invasion of gastric cancer cells.
|
28058016 |
2016 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The Arp2/3 complex is required for cell migration and invasion.
|
26867158 |
2016 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
At the molecular level, the mesenchymal-but not the epithelial-isoform of Exo70 interacts with the Arp2/3 complex and stimulates actin polymerization for tumor invasion.
|
24331928 |
2013 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The Ras-related C3 botulinum toxin substrate 1 (Rac1)-WASP-family verprolin-homologous protein-2 (WAVE2)-actin-related protein 2/3 (Arp2/3) signaling pathway has been identified to be involved in cell migration and invasion in various types of cancer cell.
|
27052944 |
2016 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Thus, C. trachomatis activates Rac and promotes its interaction with WAVE2 and Abi-1 to activate the Arp2/3 complex resulting in the induction of actin cytoskeletal rearrangements that are required for invasion.
|
17501982 |
2007 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Rac1 and Cdc42 belong to the Rho family of genes that, together with their downstream effectors, Wiskott-Aldrich Syndrome protein-family verprolin-homologous protein 2 (WAVE2) and Arp2/3, assume a vital part in cytoskeletal rearrangement and the arrangement of film projections that advance malignant cell relocation and invasion.
|
29455393 |
2018 |